| RASSF8 High (N=267) |
RASSF8 Low (N=268) |
P-value | |
|---|---|---|---|
| sex | |||
| FEMALE | 91 (34.1%) | 95 (35.4%) | 0.81 |
| MALE | 176 (65.9%) | 173 (64.6%) | |
| age | |||
| older | 131 (49.1%) | 137 (51.1%) | 0.697 |
| younger | 136 (50.9%) | 131 (48.9%) | |
| stage | |||
| I/II | 176 (65.9%) | 153 (57.1%) | 0.0445 |
| III/IV | 91 (34.1%) | 115 (42.9%) | |
| grade | |||
| G1 | 7 (2.6%) | 7 (2.6%) | 0.167 |
| G2 | 126 (47.2%) | 105 (39.2%) | |
| G3 | 103 (38.6%) | 106 (39.6%) | |
| G4 | 29 (10.9%) | 46 (17.2%) | |
| GX | 2 (0.7%) | 4 (1.5%) | |
| T | |||
| T1/2 | 182 (68.2%) | 163 (60.8%) | 0.0921 |
| T3/4 | 85 (31.8%) | 105 (39.2%) | |
| N | |||
| N0 | 120 (44.9%) | 120 (44.8%) | 0.882 |
| N1 | 7 (2.6%) | 9 (3.4%) | |
| NX | 140 (52.4%) | 139 (51.9%) | |
| M | |||
| M0 | 221 (82.8%) | 203 (75.7%) | 0.0419 |
| M1 | 36 (13.5%) | 42 (15.7%) | |
| MX | 10 (3.7%) | 23 (8.6%) | |
| pharmaceutical | |||
| NO | 244 (91.4%) | 216 (80.6%) | <0.001 |
| YES | 23 (8.6%) | 52 (19.4%) | |
| smoking | |||
| less | 149 (55.8%) | 152 (56.7%) | 0.9 |
| more | 118 (44.2%) | 116 (43.3%) | |
| Event | |||
| 0 | 194 (72.7%) | 168 (62.7%) | 0.0176 |
| 1 | 73 (27.3%) | 100 (37.3%) |